Red Cat Holdings Inc
For the period ended Jul 31, 2024. Filed Sep 23, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2024 · Filed Sep 23, 2024
Contents
Item 1. FINANCIAL STATEMENTS
Condensed Consolidated Balance Sheets
| July 31, | April 30, | |
|---|---|---|
| 2024 | 2024 | |
| ASSETS | ||
| Current assets | ||
| Cash | $7,732,763 | $6,067,169 |
| Accounts receivable, net | 681,775 | 4,361,090 |
| Inventory | 10,462,934 | 8,007,237 |
| Other | 2,592,679 | 3,962,053 |
| Total current assets | 21,470,151 | 22,397,549 |
| Goodwill | 8,995,500 | 9,088,550 |
| Intangible assets, net | 3,617,060 | 3,794,389 |
| Equity method investee | — | 5,142,500 |
| Note receivable | — | 4,000,000 |
| Property and equipment, net | 2,143,919 | 2,340,684 |
| Other | 293,126 | 293,126 |
| Operating lease right-of-use assets | 1,435,475 | 1,480,814 |
| Total long-term assets | 16,485,080 | 26,140,063 |
| TOTAL ASSETS | $37,955,231 | $48,537,612 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $2,081,568 | $1,580,422 |
| Accrued expenses | 1,296,931 | 1,069,561 |
| Debt obligations - short term | 599,570 | 751,570 |
| Customer deposits | 50,039 | 53,939 |
| Operating lease liabilities | 202,404 | 195,638 |
| Total current liabilities | 4,230,512 | 3,651,130 |
| Operating lease liabilities | 1,269,185 | 1,321,952 |
| Total long-term liabilities | 1,269,185 | 1,321,952 |
| Commitments and contingencies (Note 17) | ||
| Stockholders' equity | ||
| Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 4,676 | 47 | 47 |
| Common stock - shares authorized 500,000,000; issued and outstanding 74,890,248 and 74,289,351 | 74,890 | 74,289 |
| Additional paid-in capital | 125,927,705 | 124,616,305 |
| Accumulated deficit | (93,547,108) | (81,130,732) |
| Accumulated other comprehensive income (loss) | — | 4,621 |
| Total stockholders' equity | 32,455,534 | 43,564,530 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $37,955,231 | $48,537,612 |
Condensed Consolidated Statements of Operations and Comprehensive Income
| Three months ended July 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenues | $2,776,535 | $1,748,129 |
| Cost of goods sold | 3,259,926 | 1,573,464 |
| Gross (loss) profit | (483,391) | 174,665 |
| Operating Expenses | ||
| Research and development | 1,626,440 | 1,353,551 |
| Sales and marketing | 2,041,511 | 1,288,760 |
| General and administrative | 3,483,095 | 2,863,758 |
| Impairment loss | 93,050 | — |
| Total operating expenses | 7,244,096 | 5,506,069 |
| Operating loss | (7,727,487) | (5,331,404) |
| Other (income) expense | ||
| Loss on sale of equity method investment | 4,008,357 | — |
| Equity method loss | 734,143 | — |
| Investment loss, net | — | 239,490 |
| Interest (income) expense, net | (24,554) | 21,857 |
| Other, net | (29,057) | 1,544 |
| Other expense | 4,688,889 | 262,891 |
| Net loss from continuing operations | (12,416,376) | (5,594,295) |
| Loss from discontinued operations | — | (242,573) |
| Net loss | $(12,416,376) | $(5,836,868) |
| Other comprehensive income (loss) | ||
| Change in foreign currency translation adjustments | (4,621) | 1,646 |
| Unrealized gain on marketable securities | — | 289,389 |
| Other comprehensive loss | $(12,420,997) | $(5,545,833) |
| Loss per share - basic and diluted | ||
| Continuing operations | $(0.17) | $(0.11) |
| Discontinued operations | — | — |
| Loss per share - basic and diluted | $(0.17) | $(0.11) |
| Weighted average shares outstanding - basic and diluted | 74,500,480 | 54,935,339 |
Condensed Consolidated Statements of Shareholders’ Equity
| Series B · Additional · Accumulated Other | ||||||||
|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Common Stock · Paid-in · Accumulated · Comprehensive · Total | ||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Income (Loss) | Equity | |
| Balances, April 30, 2023, as restated | 986,676 | $9,867 | 54,568,065 | $54,568 | $112,642,726 | (57,078,103) | $(861,117) | $54,767,941 |
| Stock based compensation | — | — | — | — | 911,606 | — | — | 911,606 |
| Vesting of restricted stock units | — | — | 155,476 | 155 | (8,675) | — | — | (8,520) |
| Conversion of preferred stock | (982,000) | (9,820) | 818,334 | 818 | 9,002 | — | — | — |
| Unrealized gain on marketable securities | — | — | — | — | — | — | 289,389 | 289,389 |
| Currency translation adjustments | — | — | — | — | — | — | 1,646 | 1,646 |
| Net loss | — | — | — | — | — | (5,836,868) | — | (5,836,868) |
| Balances, July 31, 2023 | 4,676 | $47 | 55,541,875 | $55,541 | $113,554,659 | (62,914,971) | $(570,082) | $50,125,194 |
| Balances, April 30, 2024 | 4,676 | $47 | 74,289,351 | $74,289 | $124,616,305 | (81,130,732) | $4,621 | $43,564,530 |
| Stock based compensation | — | — | — | — | 1,446,038 | — | — | 1,446,038 |
| Vesting of restricted stock units | — | — | 293,302 | 293 | (134,330) | — | — | (134,037) |
| Exercise of warrants | — | — | 307,595 | 308 | (308) | — | — | — |
| Currency translation adjustments | — | — | — | — | — | — | (4,621) | (4,621) |
| Net loss | — | — | — | — | — | (12,416,376) | — | (12,416,376) |
| Balances, July 31, 2024 | 4,676 | $47 | 74,890,248 | $74,890 | $125,927,705 | (93,547,108) | $— | $32,455,534 |
Condensed Consolidated Statements of Cash Flows
| Three months ended July 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash Flows from Operating Activities | ||
| Net loss | $(12,416,376) | $(5,836,868) |
| Net loss from discontinued operations | — | (242,573) |
| Net loss from continuing operations | (12,416,376) | (5,594,295) |
| Adjustments to reconcile net loss to net cash from operations: | ||
| Stock based compensation - options | 357,258 | 629,426 |
| Stock based compensation - restricted units | 1,088,780 | 282,180 |
| Amortization of intangible assets | 177,329 | 217,368 |
| Realized loss from sale of marketable securities | — | 292,636 |
| Depreciation | 296,722 | 101,001 |
| Loss on sale of equity method investment and note receivable | 4,008,357 | — |
| Equity method loss | 734,143 | — |
| Impairment on goodwill and intangible assets | 93,050 | — |
| Changes in operating assets and liabilities | ||
| Accounts receivable | 3,679,315 | (780) |
| Inventory | (2,455,697) | (455,871) |
| Other | 1,369,374 | (1,756,973) |
| Operating lease right-of-use assets and liabilities | (662) | (458) |
| Customer deposits | (3,900) | (110,863) |
| Accounts payable | 501,146 | (569,876) |
| Accrued expenses | 222,749 | 40,436 |
| Net cash used in operating activities of continuing operations | (2,348,412) | (6,926,069) |
| Cash Flows from Investing Activities | ||
| Purchases of property and equipment | (99,957) | (5,054) |
| Proceeds from sale of marketable securities | — | 4,888,399 |
| Proceeds from sale of equity method investment and note receivable | 4,400,000 | — |
| Net cash provided by investing activities of continuing operations | 4,300,043 | 4,883,345 |
| Cash Flows from Financing Activities | ||
| Payments under debt obligations | (152,000) | (137,989) |
| Payments of taxes related to equity transactions | (134,037) | (8,520) |
| Net cash used in financing activities of continuing operations | (286,037) | (146,509) |
| Discontinued operations | ||
| Operating activities | — | (356,109) |
| Investing activities | — | — |
| Financing activities | — | 237,814 |
| Net cash used in discontinued operations | — | (118,295) |
| Net increase (decrease) in Cash | 1,665,594 | (2,307,528) |
| Cash, beginning of period | 6,067,169 | 3,260,305 |
| Cash, end of period | 7,732,763 | 952,777 |
| Less: Cash of discontinued operations | — | (15,021) |
| Cash of continuing operations, end of period | $7,732,763 | $937,756 |
| Cash paid for interest | $6,295 | $22,590 |
| Cash paid for income taxes | $— | $— |
| Non-cash transactions | ||
| Unrealized gain on marketable securities | $— | $289,389 |
| Conversion of preferred stock into common stock | $— | $9,820 |
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 – The Business
The Company was originally incorporated in February 1984. Since April 2016, the Company’s primary business has been to provide products, services, and solutions to the drone industry which it presently does through its wholly owned operating subsidiaries. Beginning in January 2020, the Company expanded the scope of its drone products and services through four acquisitions, including:
| A. | In January 2020, the Company acquired Rotor Riot, a provider of First Person View (“FPV”) drones and equipment, primarily to consumers. The purchase price was $1,995,114. |
| B. | In November 2020, the Company acquired Fat Shark Holdings, Ltd. (“Fat Shark”), a provider of FPV video goggles to the drone industry. The purchase price was $8,354,076. |
| C. | In May 2021, the Company acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $2,791,012. |
| D. | In August 2021, the Company acquired Teal Drones, Inc. (“Teal”), a leader in commercial and government Unmanned Aerial Vehicles (“UAV”) technology. The purchase price was $10,011,279. |
Following the Teal acquisition in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment (“Enterprise”) and the Consumer segment (“Consumer”) to focus on the unique opportunities in each sector. Enterprise's initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.
On February 16, 2024, we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's decision to focus its efforts and capital on defense where it believes that there are more opportunities to create long term shareholder value. See Note 3 and Note 7.
On December 11, 2023, the Company completed a firm commitment underwritten public offering with ThinkEquity of 18,400,000 shares of common stock which generated gross proceeds of $9,200,000 and net proceeds of approximately $8,400,000.
Note 2 – Summary of Significant Accounting Policies
Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial statements have been included. The results of operations for the three months ended July 31, 2024 are not necessarily indicative of the results for the full year ending April 30, 2025. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended April 30, 2024, included in the Company’s Annual Report on Form 10-K.
**Restatement of Previously Issued Consolidated Financial Statements **– The Company’s Condensed Consolidated Statement of Operations and Stockholders’ Equity for the three months ended July 31, 2023, which were originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on September 19, 2023, have been restated. The Company revised its financial statements to remove derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 14, as having a derivative component.
The impacts of these restatements are detailed in the tables below:
| Originally Reported | As Restated | Change | |
|---|---|---|---|
| Change in fair value of derivative liability | $(26,520) | $— | $(26,520) |
| Net loss | $(5,810,348) | $(5,836,868) | $(26,520) |
| Originally Reported | As Restated | Change | |
|---|---|---|---|
| Additional paid-in capital | $110,905,033 | $113,554,659 | $2,649,626 |
| Accumulated deficit | $(60,397,141) | $(62,914,971) | $(2,517,830) |
| Total equity | $49,993,398 | $50,125,194 | $131,796 |
Principles of Consolidation –Our condensed consolidated financial statements include the accounts of our wholly owned subsidiaries which include Teal and Skypersonic as well as Rotor Riot and Fat Shark through the sale date of February 16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.
The Consumer segment businesses are characterized as discontinued operations in these financial statements. The operating results and cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3.
Use of Estimates – The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment, and (iii) the evaluation of other-than-temporary-impairment of equity method investments.
**Concentration of Credit Risk **– Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable, net as of July 31, 2024 and April 30, 2024 were as follows:
| July 31, 2024 | April 30, 2024 | |
|---|---|---|
| Customer A | 38% | 53% |
| Customer B | 25% | 24% |
As of July 31, 2024, three customers accounted for equal to or greater than 10% of total revenue, totaling 32%, 20% and 12%, respectively. As of July 31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively.
**Equity Method Investment –**The equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $11,353,875 for the year ended April 30, 2024. See Note 7 for additional information.
Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures – The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.
The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
The guidance establishes three levels of the fair value hierarchy as follows:
Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
The Company's financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of these instruments approximates fair value due to their short-term nature.
**Revenue Recognition **– The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation is satisfied. The Company’s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $50,039 and $53,939 at July 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $0 and $1,477,859 at July 31, 2024 and April 30, 2024, respectively.
The following table presents the Company’s revenue disaggregated by revenue type:
| Three Months Ended July 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Contract related | $886,440 | $310,881 |
| Product related | 1,890,095 | 1,437,248 |
| Total | $2,776,535 | $1,748,129 |
**Product Warranty -**The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses. Warranty liability was approximately $541,000 and $372,000 as of July 31, 2024 and April 30, 2024 respectively.
**Recent Accounting Pronouncements ** –Management does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.
**Comprehensive Loss **– Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the three months ended July 31, 2024 and July 31, 2023, comprehensive loss was $4,621 higher and $291,035 lower than net loss, respectively, related to unrealized gains on available-for-sale securities totaling $0 and $289,389, respectively, and foreign currency translation adjustments of $4,621 and $1,646.
Basic and Diluted Net Loss per Share – Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would have been anti-dilutive include:
| July 31, 2024 | July 31, 2023 | |
|---|---|---|
| Series B Preferred Stock, as converted | 3,896 | 3,896 |
| Stock options | 7,319,988 | 6,884,017 |
| Warrants | 1,821,291 | 1,539,999 |
| Restricted stock | 2,202,599 | 842,701 |
| Total | 11,347,774 | 9,270,613 |
Related Parties – Parties are considered to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related Party transactions are disclosed in Note 16.
**Liquidity and Going Concern **– The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs incurred to pursue its long-term growth strategy. During the three months ended July 31, 2024, the Company incurred a net lossof approximately $12,000,000 and used cash in operating activities of approximately $2,300,000. As of July 31, 2024, working capital totaled approximately $17,200,000. These financial results and our financial positionat July 31, 2024 raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen its liquidity. On December 11, 2023, we completed a public offering of 18,400,000 shares of common stock which generated net proceeds of approximately $8,400,000 as further described in Note 1 and Note 12. In addition, the Company’s operating plan for the next twelve months has been updated to reflect recent operating improvements. Revenues have accelerated and are expected to continue growing. The Company’s manufacturing facility is scaling production and gross profits are projected to increase. If necessary, the Company will seek to obtain additional debt financing for which there can be no guarantee. As described in Note 7, the Company sold its equity method investment for $4,400,000 in July 2024. As described in Note 18, the Company closed a financing with proceeds of $8 million to be received in late September 2024. Management has concluded that these recent positive developments alleviate any substantial doubt about the Company’s ability to continue its operations, and meet its financial obligations, for twelve months from the date these consolidated financial statements are issued.
Note 3 – Divestiture of Consumer Segment
On February 16, 2024, the Company closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement dated November 21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the “SPA”). The transaction closed concurrently with UMAC’s initial public offering and listing on the NYSE American exchange (“IPO”) under the symbol “UMAC.”
The total consideration received by the Company was valued at $20 million and consisted of i) $1 million in cash, ii) $2 million in a secured promissory note (“Promissory Note”), iii) $17 million in securities of Unusual Machines, and iv) a post-closing adjustment for excess working capital.
Secured Promissory Note
The Promissory Note from Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires monthly payments of interest due in arrears on the 15th day of each month. In the event of a Qualified Financing (defined as one or more related debt or equity financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC’s completed IPO), the Company may require payment of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified Financing. During the occurrence and continuance of any event of default under the Note, the Company may, at its option, convert the amounts due under the Note to common stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount to the average daily volume weighted average price for UMAC’s common stock over the 10 days preceding the conversion price. Conversions under the Note will be limited such that no conversion may be made to the extent that, after giving effect to the conversion, the Company, together with its affiliates, would beneficially own in excess of 4.99% of UMAC’s common stock. This limit may be increased by the Company upon 61 days written notice.
Unusual Machines Securities
**The $17 million worth of UMAC common stock was valued at the IPO price for UMAC’s common stock of $4.00 per share, resulting in 4,250,000 shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC’s issued and outstanding common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of the IPO).
Working Capital
The purchase price was adjusted for working capital as of the closing date. Actual working capital excess amounts increased the principal amount of the Promissory Note dollar for dollar. Working capital as of closing was finalized at $2 million in July 2024. As a result, UMAC issued the Company $4,000,000 of its 8% Promissory Notes due November 30, 2025 (the “New Notes”) reflecting (i) satisfaction and settlement of working capital adjustments and (ii) a maturity date extension to November 30, 2025.
The Consumer segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards. Set forth below are the results of operations for the Consumer segment for:
| 2024 | 2023 | |
|---|---|---|
| Revenues | $— | $1,869,219 |
| Cost of goods sold | — | 1,385,116 |
| Gross Profit | — | 484,103 |
| Operating Expenses | ||
| Research and development | — | 46,249 |
| Sales and marketing | — | 404,104 |
| General and administrative | — | 253,586 |
| Total operating expenses | — | 703,939 |
| Operating loss | — | (219,836) |
| Other expense (income) | ||
| Interest expense | — | 22,856 |
| Other, net | — | (119) |
| Other expense | — | 22,737 |
| Net loss from discontinued operations | $— | $(242,573) |
Note 4 – Inventories
Inventories consisted of the following:
| July 31, 2024 | April 30, 2024 | |
|---|---|---|
| Raw materials | $6,863,187 | $5,750,324 |
| Work-in-process | 1,622,121 | 1,289,997 |
| Finished goods | 1,977,626 | 966,916 |
| Total | $10,462,934 | $8,007,237 |
Note 5 – Other Current Assets
Other current assets included:
| July 31, 2024 | April 30, 2024 | |
|---|---|---|
| Prepaid expenses | $2,387,937 | $1,206,306 |
| Prepaid inventory | 204,742 | 602,888 |
| Contract asset | — | 1,477,859 |
| Grant receivable | — | 675,000 |
| Total | $2,592,679 | $3,962,053 |
Note 6 – Intangible Assets
Intangible assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:
| July 31, 2024 | April 30, 2024 | |||||
|---|---|---|---|---|---|---|
| Gross Value | Accumulated Amortization | Net Value | Gross Value | Accumulated Amortization | Net Value | |
| Proprietary technology | $4,282,001 | $(2,094,941) | $2,187,060 | $4,282,001 | $(1,917,612) | $2,364,389 |
| Non-compete agreements | 65,000 | (65,000) | — | 65,000 | (65,000) | — |
| Total finite-lived assets | 4,347,001 | (2,159,941) | 2,187,060 | 4,347,001 | (1,982,612) | 2,364,389 |
| Brand name | 1,430,000 | — | 1,430,000 | 1,430,000 | — | 1,430,000 |
| Total indefinite-lived assets | 1,430,000 | — | 1,430,000 | 1,430,000 | — | 1,430,000 |
| Total intangible assets, net | $5,777,001 | $(2,159,941) | $3,617,060 | $5,777,001 | $(1,982,612) | $3,794,389 |
Proprietary technology and non-compete agreements are being amortized over six years and three years, respectively. Goodwill and Brand name are not amortized but evaluated for impairment on a quarterly basis.
Note 7 – Equity Method Investment
On July 22, 2024, the Company sold all of its securities in UMAC to two unaffiliated third-party purchasers (the “Purchasers”). As part of the transaction, on July 22, 2024, the Company entered into an Exchange Agreement with UMAC pursuant to which the Company exchanged 4,250,000 shares of UMAC’s common stock, par value $0.001 per share, for 4,250 shares of UMAC’s newly designated Series A Convertible Preferred Stock (the “Series A”). The Company sold the Series A ownership interest ($4,408,357 at time of sale) and the Note Receivable of $4,000,000 to the Purchasers for $4.4 million in cash pursuant to a Purchase Agreement in a transaction that closed on July 22, 2024.
As of April 30, 2024, the Company had owned approximately a 46% interest in Unusual Machines. The primary business operations included selling first-person-view video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC’s financial statements are prepared in accordance with GAAP. See Note 3 for additional information.
Financial information for UMAC prior to the sale of the Company’s equity interest was derived from UMAC’s Form 10-Q for the six months ended June 30, 2024 and was as follows:
| Current assets | $5,116,963 |
|---|---|
| Long-term assets | 20,083,390 |
| Current liabilities | 931,200 |
| Long-term liabilities | 4,297,332 |
| Revenues | 2,030,039 |
| Gross profit | 592,607 |
| Net loss | $(2,718,240) |
The Company’s investments in UMAC have been impacted by the following:
| Initial investment, February 16, 2024 | $17,000,000 |
|---|---|
| Equity method loss | (503,625) |
| Impairment | (11,353,875) |
| Investment balance, April 30, 2024 | $5,142,500 |
| Equity method loss | (734,143) |
| Sale of ownership interest | (4,408,357) |
| Investment balance, July 31, 2024 | $— |
The computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, was based on the fair market value of UMAC’s common stock.
Note 8 – Property and Equipment
Property and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation. The reported values are periodically assessed for impairment, and were as follows:
| July 31, 2024 | April 30, 2024 | |
|---|---|---|
| Equipment and related | $1,609,269 | $1,540,888 |
| Leasehold improvements | 1,556,139 | 1,547,976 |
| Furniture and fixtures | 186,703 | 163,290 |
| Accumulated depreciation | (1,208,192) | (911,470) |
| Net carrying value | $2,143,919 | $2,340,684 |
Depreciation expense totaled $296,722 and $101,001 for the three months ended July 31, 2024 and 2023, respectively.
Note 9 – Other Long-Term Assets
Other long-term assets included:
| July 31, 2024 | April 30, 2024 | |
|---|---|---|
| SAFE agreement | $250,000 | $250,000 |
| Security deposits | 43,126 | 43,126 |
| Total | $293,126 | $293,126 |
In November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (“Firestorm”) under which it made a payment of $250,000 to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits the Company to participate in a future equity financing of Firestorm by converting the $250,000 into shares of Preferred Stock of Firestorm. If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive cash payments, or shares of stock, whichever has greater value. The Company’s investment in the SAFE agreement has been recorded on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly basis. No factors indicative of impairment were identified during the three months ended July 31, 2024.
Note 10 – Right of Use Assets and Liabilities
As of July 31, 2024, the Company had operating type leases for real estate and no finance type leases. The Company’s leases have remaining lease terms of up to 6.42 years, including options to extend certain leases for up to six years. Operating lease expense totaled $90,288 and $85,252 for the three months ended July 31, 2024 and 2023, respectively.
Leases on which the Company made rent payments during the reporting period included:
| Location | Monthly Rent | Expiration |
|---|---|---|
| South Salt Lake, Utah | $23,340 | December 2030 |
| San Juan, Puerto Rico | $5,977 | June 2027 |
| Grantsville, Utah | $1,000 | December 2026 |
Supplemental information related to operating leases for the three months ended July 31, 2024 was:
| Operating cash paid to settle lease liabilities | $90,951 |
|---|---|
| Weighted average remaining lease term (in years) | 5.93 |
| Weighted average discount rate | 12% |
Note 11 – Debt Obligations
| A. | Decathlon Capital |
On August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (“DA4”) in the amount of $1,670,294 (the “Loan”), representing the outstanding principal amount previously due and owing by Teal to DA4. Interest on the Loan accrues at a rate of ten (10%) percent per annum. Principal and interest is payable in monthly installments of $49,275 until maturity on December 31, 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $230,795 and $370,537, respectively.
| B. | Pelion Note |
In May 2021, Teal entered into a note agreement totaling $350,000 which is payable upon demand. The Note bears interest at the applicable Federal Rate as of the date of the Note which was 0.13% on the date of issuance. Accrued interest at July 31, 2024 and April 30, 2024 totaled $1,449 and $1,334, respectively.
| C. | Corporate Equity |
Beginning in October 2021, and amended in January 2022, Teal financed a total of $120,000 of leasehold improvements with Corporate Equity, LLC. The loan bears interest at 8.25% annually and requires monthly payments of $3,595 through December 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $17,205 and $27,495 respectively.
| D. | Ascentium Capital |
In September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $24,383. Monthly payments of $656 are payable through October 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $1,449 and $1,334 respectively.
| E. | Summary |
Future annual principal payments at July 31, 2024 were as follows:
| Fiscal Year Ended: | |
|---|---|
| 2025 | 599,570 |
| Thereafter | — |
| Total | $599,570 |
Note 12 – Common Stock
Our common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common stock is entitled to one vote. A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:
| Description of Shares | Shares Issued |
|---|---|
| Shares outstanding as of April 30, 2023 | 54,568,065 |
| Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes | 192,742 |
| Vesting of restricted stock to Board of Directors | 252,214 |
| Vesting of restricted stock to consultants | 1,761 |
| Conversion of preferred stock | 818,334 |
| Issuance of common stock through ATM facilities | 53,235 |
| Issuance of common stock through public offering | 18,400,000 |
| Exercise of stock options | 3,000 |
| Shares outstanding as of April 30, 2024 | 74,289,351 |
| Vesting of restricted stock to employees, net of shares withheld of 126,828 to pay taxes | 231,855 |
| Vesting of restricted stock to Board of Directors | 61,447 |
| Exercise of warrants | 307,595 |
| Shares outstanding as of July 31, 2024 | 74,890,248 |
ATM Facility
In August 2023, we entered into a sales agreement (“the 2023 ATM Facility”) with ThinkEquity LLC (“ThinkEquity”), which provides for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. In accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per share, having an aggregate offering price of up to $4,375,000. The issuance and sale of these shares by us pursuant to the 2023 ATM Facility are deemed “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), and are registered under the Securities Act. We pay a commission of up to 2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.
Due to the expiration of the registration statement that was used for the 2023 ATM Facility, and due to the disqualification of our prior auditors from appearing or practicing before the SEC, no additional securities may be sold under 2023 ATM Facility.
Public Offering
In December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the “Offering”) an aggregate of 16,000,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a public offering price of $0.50 per share. The Company also granted the underwriters a 45-day option to purchase up to an additional 2,400,000 shares of Common Stock to cover over-allotments.
The Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock which generated gross proceeds of $9,200,000. Net proceeds to the Company from the Offering, after deducting the underwriting discount, the underwriters’ fees and expenses and the Company’s estimated Offering expenses, were approximately $8,400,000.
Note 13 – Preferred Stock
Our preferred stock has a par value of $0.001 per share. Series B Preferred Stock (“Series B Stock”) is convertible into common stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an as-if-converted basis.982,000 shares of Series B Stock were converted into 818,334 shares of common stock in June 2023. Shares outstanding at July 31, 2024 totaled 4,676 which are convertible into 3,896 shares of common stock.
Note 14 – Warrants
The Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price of $1.50. The warrants were valued using the multinominal lattice The value of the warrants was included in the determination of the initial accounting for each financing.
A summary of the warrants issued were:
| Upon Issuance | ||
|---|---|---|
| Date of Transaction | Number of Warrants | Initial Fair Value |
| October 2020 | 399,998 | $267,999 |
| January 2021 | 675,000 | $2,870,666 |
To date, we have received $301,248 related to the exercise of 268,332 warrants.
In May 2021, the Company issued warrants to purchase 200,000 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $5.00.
In July 2021, the Company issued warrants to purchase 533,333 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $5.625.
In December 2023, the Company issued warrants to purchase 736,000 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $0.625.
The following table summarizes the changes in warrants outstanding since April 30, 2023.
| Number of Shares · Weighted-average Exercise Price per Share · Weighted-average Remaining Contractual Term (in years) · Aggregate Intrinsic Value | ||||||
|---|---|---|---|---|---|---|
| Balance as of April 30, 2023 | 1,539,999 | 3.38 | 2.89 | $— | ||
| Granted | 736,000 | $0.63 | ||||
| Exercised | — | — | ||||
| Outstanding as of April 30, 2024 | 2,275,999 | 2.49 | 2.77 | $— | ||
| Granted | — | — | ||||
| Exercised | (454,708) | 0.63 | ||||
| Outstanding at July 31, 2024 | 1,821,291 | $2.96 | 2.05 | $389,589 | ||
Note 15 – Share Based Awards
The 2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares issuable in connection with Awards under the Plan may not exceed 11,750,000.
| A. | Options |
The range of assumptions used to calculate the fair value of options granted during the three months ended July 31 was:
| 2024 | 2025 | |
|---|---|---|
| Exercise Price | $1.15 – 1.29 | $1.06 – 1.12 |
| Stock price on date of grant | 1.20 – 1.38 | 1.06 – 1.12 |
| Risk-free interest rate | 4.24 – 4.44% | 3.47 – 4.07% |
| Dividend yield | — | — |
| Expected term (years) | 5.24 – 5.85 | 6.00 – 6.25 |
| Volatility | 191.28 – 199.48% | 257.25 – 260.22% |
A summary of options activity under the Plan since April 30, 2023 was:
| Shares | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Term | Aggregate Intrinsic Value | |
|---|---|---|---|---|
| Outstanding as of April 30, 2023 | 4,784,809 | $1.88 | 8.72 | 74,586 |
| Granted | 2,903,542 | 1.02 | ||
| Exercised | (3,000) | 0.89 | ||
| Forfeited or expired | (905,417) | 2.27 | ||
| Outstanding as of April 30, 2024 | 6,779,934 | 1.46 | 8.02 | 2,762,242 |
| Granted | 627,500 | 1.15 | ||
| Exercised | (4,000) | 0.72 | ||
| Forfeited or expired | (83,446) | 1.55 | ||
| Outstanding as of July 31, 2024 | 7,319,988 | 1.43 | 7.54 | 5,658,470 |
| Exercisable as of July 31, 2024 | 4,444,723 | $1.65 | 6.57 | $3,014,807 |
The aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price of each option. As of July 31, 2024, there was $2,773,793 of unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized over the weighted average periods of 1.17.
| B. | Restricted Stock |
A summary of restricted stock activity under the Plan since April 30, 2023 was:
| Shares | Weighted Average Grant-Date Fair Value Per Share | |
|---|---|---|
| Unvested and outstanding as of April 30, 2023 | 781,060 | $2.44 |
| Granted | 298,643 | 1.06 |
| Vested | (485,024) | 1.92 |
| Forfeited | (419,549) | 2.09 |
| Unvested and outstanding as of April 30, 2024 | 175,130 | 2.09 |
| Granted | 2,447,599 | 1.06 |
| Vested | (420,130) | 1.25 |
| Forfeited | — | — |
| Unvested and outstanding as of July 31, 2024 | 2,202,599 | $1.11 |
| C. | Stock Compensation |
Stock compensation expense for the three months ended July 31 by functional operating expense was:
| 2024 | 2023 | |
|---|---|---|
| Research and development | $94,422 | $127,417 |
| Sales and marketing | 116,543 | 165,309 |
| General and administrative | 1,235,073 | 618,880 |
| Total | $1,446,038 | $911,606 |
Stock compensation expense pertaining to options totaled $357,258 and $629,426 for the three months ended July 31, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted stock totaled $1,088,780 and $282,180 for the three months ended July 31, 2024 and 2023, respectively.
Note 16 - Related-Party Transactions
In February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 7. UMAC’s Chief Executive Officer is a direct relative of a member of the Company’s management.
**Note 17 – Commitments and Contingencies **
Legal Proceedings
In the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. We have not recorded any litigation reserves as of July 31, 2024.
One pending legal matter is an action filed against Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.
Note 18 – Subsequent Events
Subsequent events have been evaluated through the date of this filing and there are no subsequent events which require disclosure, except as follows:
FlightWave Acquisition
On September 4, 2024, the Company, Teal, FW Acquisition, Inc. (“Buyer”), and FlightWave Aerospace Systems Corporation (“Seller”) entered into and closed on the transactions set forth in an Asset Purchase Agreement (the “APA” and the transactions set forth therein, the “Transactions”), pursuant to which Buyer purchased and Seller sold certain assets used in designing, developing, manufacturing, and selling long range, AI-powered UAVs for commercial use.
As a condition to the closing of the Transactions, each of the shareholders of the Seller entered into a Joinder Agreement with the Company, Teal and Buyer pursuant to which such shareholder agreed to the terms of the APA and agreed to be bound by the provisions thereof applicable to the Seller’s shareholders, including without limit, the indemnification provisions in the APA.
The purchase price under the APA is equal to $14 million worth of shares of the Company’s common stock which are payable as follows:
| • | $7 million worth of the Company’s common stock to be issued on September 30, 2024, at a price per share equal to the VWAP on such date, which shall be payable to the preferred shareholders of the Seller as set forth in the APA. |
| • | $7 million worth of the Company’s common stock to be issued on December 31, 2024, at a price per share equal to the VWAP on such date, of which (i) $2 million will be payable to preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders and option-holders of the Seller as set forth the APA. |
Promissory Note
On September 23, 2024, we entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management X LLC (“Lind”). Under the SPA, within days of closing, we will receive $8 million in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $9,600,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our common stock at a price of $6.50 per share, exercisable for 5 years (the “Warrant”). As addition consideration to Lind, we have agreed to pay a commitment fee in the amount of $280,000, which may be paid by deduction from the funding to be received.
The Note, which does not accrue interest, shall be repaid in eighteen (18) consecutive monthly installments in the amount of $533,334 beginning six months from the issuance date. At our option, monthly payments can be increased up to $1,000,000 so long as our market capitalization is at least $50 million. In addition, if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment amount up to $1,300,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.
The Note may be converted by Lind from time to time at a price of $6.50 per share (the “Conversion Price”). The dollar amount of any conversions by Lind will be applied to toward upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days’ notice, but in the event of a prepayment notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share Price is equal to or greater than $2.00) or the Conversion Price.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.